| Sanjivani Paranteral Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531569 |
NSE Symbol : - |
P/E(TTM) : 26.56 |
|
ISIN Demat : INE860D01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.64 |
|
Book Value(₹) : 39.39 |
Market Cap(₹Cr) : 184.02 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 10.51 | 20.86 | 15.50 | 17.89 | 18.18 | 17.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10.51 | 20.86 | 15.50 | 17.89 | 18.18 | 17.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.75 | 0.29 | 0.16 | 0.04 | 0.43 | 0.31 |
| Total Income | 11.26 | 21.15 | 15.66 | 17.93 | 18.61 | 17.66 |
| Total Expenditure | 9.60 | 17.27 | 13.25 | 15.24 | 15.56 | 14.80 |
| PBIDT | 1.66 | 3.88 | 2.41 | 2.68 | 3.05 | 2.86 |
| Interest | 0.06 | 0.21 | 0.05 | 0.22 | 0.20 | 0.19 |
| PBDT | 1.60 | 3.68 | 2.36 | 2.46 | 2.84 | 2.67 |
| Depreciation | 0.35 | 0.19 | 0.17 | 0.16 | 0.18 | 0.16 |
| Tax | -0.12 | 0.87 | 0.53 | 0.57 | 0.05 | 0.61 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.44 | 0.00 | 0.02 | 0.00 | 0.41 | 0.00 |
| Reported Profit After Tax | 0.94 | 2.62 | 1.64 | 1.73 | 2.19 | 1.90 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.94 | 2.62 | 1.64 | 1.73 | 2.19 | 1.90 |
| EPS (Unit Curr.) | 0.80 | 2.13 | 1.33 | 1.46 | 1.84 | 1.62 |
| EPS (Adj) (Unit Curr.) | 0.80 | 2.13 | 1.33 | 1.46 | 1.84 | 1.62 |
| Calculated EPS (Unit Curr.) | 0.76 | 2.13 | 1.33 | 1.46 | 1.85 | 1.62 |
| Calculated EPS (Adj) (Unit Curr.) | 0.76 | 2.13 | 1.33 | 1.46 | 1.85 | 1.62 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.05 | 8.52 | 5.34 | 5.83 | 7.38 | 6.50 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.05 | 8.52 | 5.34 | 5.83 | 7.38 | 6.50 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.28 | 12.28 | 12.28 | 11.88 | 11.88 | 11.68 |
| Reserve & Surplus | 0.00 | 0.00 | 32.55 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 15.79 | 18.60 | 15.55 | 14.98 | 16.78 | 16.48 |
| PBDTM(%) | 15.22 | 17.64 | 15.23 | 13.75 | 15.62 | 15.39 |
| PATM(%) | 8.94 | 12.56 | 10.58 | 9.67 | 12.05 | 10.95 |
